Please login to the form below

Not currently logged in
Email:
Password:

Genesis Biopharma names Hans Bishop as chair

Former chief operating officer of Dendreon joins specialist in cancer immunotherapies

Former chief operating officer of Dendreon Hans Bishop has been appointed executive chair of the board at Genesis Biopharma.

The US biotech specialises in cancer immunotherapies and Bishop first joined Genesis as a director in the beginning of 2012.

He will take over from Anthony Cataldo who will remain at the firm as a director.

“To support our business plan we have been expanding our leadership with talented, experienced professionals,” said Cataldo.

“The addition of Hans as our executive chair further enhances this dynamic team as he is a proven leader with an impressive track record of enhancing operational and financial results.”

Prior to his role at Dendreon, Bishop served as president of Bayer's speciality medicine business division from 2006 until 2009, leading units in oncology, neurology, ophthalmology and haematology.

From 2004 to 2006 he held the position of senior VP, global commercial operations for Chiron Corporation, now part of Novartis.

Commenting on his appointment, Bishop said: “It is a privilege to serve as executive chair of Genesis Biopharma at this important point in the company's evolution.  I look forward to building a strong leadership team & working with my colleagues on the board to steer the company to success.”

30th March 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hive

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...

Infographics